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ABSTRACT
Background/aims To investigate the incidence of Nd:
YAG-laser treatment for posterior capsular opaciﬁcation
(PCO) over a period of 5 years from phacoemulsiﬁcation
in an unselected population, comparing outcomes for
three acrylic intraocular lenses (IOLs).
Methods Retrospective longitudinal cohort study
comprising 900 eyes. Three subgroups of 300 eyes,
receiving the AR40, AR40e (Abbott Medical Optics,
Santa Ana, California), or BL27 (Bausch & Lomb,
Rochester, New York) IOL respectively, were compared.
Data on patient age, gender, IOL type, dates of cataract
surgery, Nd:YAG-laser treatment and/or death, and visual
acuities before/after cataract surgery/Nd:YAG-laser
treatment were collected from ﬁve sources: cataract
operation register, patient administration system, quality
control system for cataract operations, Nd:YAG-laser
treatment register and clinical patient records.
Results 216 eyes (24%) received Nd:YAG-laser
treatment over a 5-year period. Statistically signiﬁcant
differences (p<0.001, c
2 test) were found between
treatment rates for the three IOLs: AR40 73 eyes (24%),
BL27 91 eyes (30%) and AR40e 52 eyes (17%). Eyes of
patients who died during the follow-up period had fewer
treatments (23/266, 8.6%) than eyes of patients living
(193/634, 30%) at the end of the follow-up period.
Conclusion In comparison with a hydrophobic acrylic
IOL with sharp posterior optic edge, a hydrophilic acrylic
IOL was associated with almost twice the number of Nd:
YAG-laser treatments over the 5-year period. The results
are useful for discussing the economic long-term
consequences of choosing an IOL with a design that
makes PCO development more or less likely. Caution is
advised when applying data from post-mortem PCO
studies on living populations.
INTRODUCTION
Posterior capsular opaciﬁcation (PCO) is arguably
the most signiﬁcant cause of visual problems after
cataract surgery, the world’s most commonly
performed operation. Visual acuity and subjective
self-assessed visual function correlate to objective
measurements of PCO and are improved by Nd:
YAG-laser capsulotomy (hereinafter referred to as
capsulotomy).
1e3 Treatment, however, burdens the
limited resources of healthcare systems. In 2007,
72306 cataract operations were reported to the
Swedish National Cataract Register.
4 Publicly
ﬁnanced departments of ophthalmology in Sweden
reported that year on average capsulotomies corre-
sponding to 15% of their cataract operation volume
(range 2e27%) (Swedish Ophthalmological Society:
Verksamhetsberättelse för ögonsjukvården 2007,
Annual report on ophthalmic healthcare 2007).
Moreover, in developing countries, Nd:YAG-laser
access can be limited. Reducing PCO development is
therefore important. Proper surgical technique and
intraocular lens (IOL) designdmaterial, optic edge
proﬁle and haptic constructiondstands out as
a major factor in minimising PCO.
5e9
For grading extent and monitoring successive
development of PCO, computerised analysis of
high-resolution digital photographs has replaced
the previously common counting of capsulotomies,
which, according to Buehl et al, should be
avoided.
10e12 In PCO research, a randomised
prospective design is considered the gold standard
and is chosen for meta-analyses in the ﬁeld.
10 13 14
Certainly reasonable when comparing PCO
preventing measures, IOL designs, etc, this design
has limitations when information is requested
about the actual number of capsulotomies in
a population undergoing cataract surgery. An
attempt to model demand for capsulotomy based
upon previous studies underestimated the actual
need.
15
In the central and western areas of the county of
Östergötland, Sweden, the only care-provider
offering cataract surgery (1400e2000 performed
annually) and capsulotomy (250e360 performed
annually) to approximately 250000 citizens is the
Department of Ophthalmology, Linköping Univer-
sity Hospital. These conditions make retrospective
follow-up investigations relatively reliable regarding
data completeness and/or description of dropouts.
Patient cost for treatment/examination by a doctor
within the public healthcare system is SEK 250
(€23, £19.50, $32, currency rates as of 18 June 2009),
and the treating doctor is not reimbursed for
capsulotomies. Over-/undertreatment for economic
reasons is therefore unlikely. Instead, visual prob-
lems and posterior capsule appearance form the
main basis for the decision to treat.
This epidemiological, longitudinal retrospective
cohort study aims to describe the number of
capsulotomies performed in a population of unse-
lected cataract operated patients over a period of
5 years after phacoemulsiﬁcation surgery and to
examine the inﬂuence of mortality on the remaining
number of eyes in potential need of future treat-
ment. Three subpopulations receiving three
different IOL types were investigated.
MATERIALS AND METHODS
Register data and patient record ﬁles for 900
phacoemulsiﬁcation cataract surgeries performed
between January 2000 and September 2002 at the
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were retrospectively reviewed. During this period, three different
acrylic IOL types were in common use at the clinic:
Abbott Medical Optics (AMO) AR40, a hydrophobic three-piece
IOL with rounded posterior optic edge (implanted
JanuaryeNovember 2000), AMO AR40e, similar to AR40 except
for a sharp posterior optic edge (implanted November
2001eSeptember 2002) and Bausch&Lomb BL27, a hydrophilic
1-piece IOL with sharp posterior edge and two non-angulated
loop haptics (implanted October 2000eApril 2002). Figure 1
illustrates the IOL designs.
Several surgeons performed the phacoemulsiﬁcation surgeries,
all in topical anaesthesia except for a small percentage where
general anaesthesia was indicated. Clear corneal incision,
continuous curvilinear capsulorhexis created with microforceps
and implantation of the IOL in the capsule using an injector
were performed in all cases. The three IOLs in this study were all
available as ‘standard IOLs’ at the clinic during different time
periods. The BL27 was more commonly preferred by one surgeon
(BJ), while the use of AMO IOLs was more evenly distributed
among the surgeons (including BJ). Surgeon experience level and
phacoemulsiﬁcation technique were the same regardless of IOL.
Several ophthalmologists, without correlation to which cataract
surgeon performed the phacoemulsiﬁcation, performed the
capsulotomies.
The following data were extracted and transferred to an Excel
database: patient age and gender, IOL type, dates of cataract
surgery anddwhere applicableddate(s) of capsulotomy and/or
death. Visual acuities (VA), in clinical practice measured with
Snellens’ letter chart at 5 m’ distance, before and after cataract
surgery, and, where applicable/retrievable, before and after
capsulotomy were recorded.
Patients and dates of operation were identiﬁed through the
manual operation register, in which patient identiﬁcation
numbers and IOL identiﬁcation labels were entered. For each IOL
type, 300 operations were consecutively enrolled. The clinic’s
digital quality control register for cataract operations provided
information on visual acuity (VA) before and after surgery, and
details of surgery were also recorded here. The digital patient
administration system where each contact with the clinic was
registered was used to track visits to the clinic after surgery. This
system receives updates from the national population register as
regards patient deaths. Clinical patient records (paper) and/or
manual registers for capsulotomies were used to conﬁrm and/or
add data on capsulotomy and visual acuity (ﬁgure 2).
Cases were excluded if capsule damage during the surgery
precluded secure placement of the IOL in the capsular bag.
Minimal posterior capsular rupture or use of capsular tension
ring did not prevent inclusion as long as the IOL could be placed
completely in the bag with an intact anterior capsulorhexis.
Cases with inconclusive data regarding capsulotomy were
excluded.
The Regional Ethical Review Board in Linköping approved the
study.
Figure 1 Top left: front photograph of BL27 (Bausch & Lomb, Rochester, New York) intraocular lens (IOL): hydrophilic acrylic single-piece IOL with two
closed-loop non-angulated haptics. Bottom left: scanning electron microscope picture of the sharp (‘square’) posterior edge. Top centre and right:
drawings of AR40e (Abbott Medical Optics, Santa Ana, California) IOL: three-piece IOL with hydrophobic acrylic optic and two angulated PMMA
haptics. Bottom centre: bottom arrow indicates the sharp posterior edge. The AR40 (Abbott Medical Optics, Santa Ana, California) IOL design is
identical to the AR40e except that the posterior optic edge is rounded. (Use of the illustrations has been granted by the two manufacturers.)
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For power calculation, pilot samples of 100 eyes per IOL were
used for a computerised simulation of the logrank test. Five
hundred simulations were performed for 11 sample sizes, n¼20
to n¼500. A sample size of 300 cases for each IOL was chosen for
an estimated power of 84.6%, in order to establish differences
between groups on the level p<0.05.
For comparison of survival curves, the logrank test feature of
the statistical software Minitab v.15 was applied.
The Student t test and c
2 test were used to evaluate the
statistical signiﬁcances of differences between groups in the
cross-sectional data, age, etc. A p level of <0.05 was considered
statistically signiﬁcant.
RESULTS
Of 900 eyes included in the study 571 (63%) belonged to
females, and 329 (37%) to males. The mean age at surgery was
76.7, median age 78.9. Figure 3 (top) shows the age/gender
distributions at surgery. Two hundred and sixteen eyes (24%) had
been treated with Nd:YAG-laser 5 years after the phacoemulsi-
ﬁcation surgery. Of the treated eyes, 148 (69%) belonged to
females and 68 (31%) to males. The mean age at capsulotomy
was 76.8, median age 78.8 (ﬁgure 3, bottom).
In ﬁgure 4, the incidence of capsulotomy during the study
period is shown for all eyes (thickest curve) and for the three
different IOL subgroups. Five years after cataract operation,
capsulotomy had been made in 73 eyes with the AR40 IOL, in 91
eyes with the BL27 IOL and in 52 eyes with the AR40e IOL,
a statistically signiﬁcant difference (p<0,001, c
2 test).
In 266 (30%) of the 900 cases, the patient died before the end
of the 5-year follow-up period. Figure4 also shows the number of
eyes remaining with intact capsules in living patients (second
thickest curve). Four hundred and forty-one eyes were thus still
eligible for capsulotomy at the end of the follow-up period. With
both capsulotomy and death included in the analysis of the
survival curves, there is no statistically signiﬁcant difference
between the three IOLs (p¼0.11, logrank test).
Of the 266 eyes belonging to patients who died during the
study period, 23 (8.6%) had received a capsulotomy, a clearly
lower proportion than in the population still alive 5 years
after cataract operation where 193 of 634 eyes (30%) received
treatment.
Data on VA before phacoemulsiﬁcation were retrievable for all
eyes operated on except one, and before capsulotomy for 215 of
216 treated eyes. After phacoemulsiﬁcation, VA was not
recorded in six cases, and in 13 cases postoperative records were
unretrievable. VA after capsulotomy was recorded for 107 of 216
eyes, and for one eye no record was retrievable. Figure 5 shows
VA distributions before and after phacoemulsiﬁcation and
capsulotomy respectively. Although some cases returned with
worse VA due to PCO compared with VA before phacoemulsiﬁ-
cation, a larger proportion of eyes had a higher VA before PCO
treatment than before phacoemulsiﬁcation.
DISCUSSION
This study describes the demand over time for Nd:YAG-laser
capsulotomy against visually disturbing PCO, during a follow-
up period of 5 years after phacoemulsiﬁcation cataract surgery in
a non-selected population. Of 900 eyes operated on, 216 had
capsulotomy. Patients who died before the end of follow-up were
not excluded, in order to optimally describe the clinical outcomes
in a group undergoing cataract extraction. During the follow-up
period, 266 eyes left the study because the patient died. Of these,
243 had intact posterior capsules. After 5 years, 441 eyes thus
remained eligible for potential future capsulotomy.
The 5-year mortality in this cataract-operated population is
similar to the ﬁndings of a British study where 933 patients
operated on in 2000 were followed up to the end of 2006, at
Figure 2 Data-acquisition ﬂow chart.
Study patients were enrolled (black
arrow) through the manual operation
register (top), which also provided basic
information: date of birth, gender, date of
cataract operation and type of
intraocular lens (IOL). The digital
databases (cylinders) and paper records
provided additional data as indicated
(grey arrows). Paper records were not
retrieved in all cases (dotted contours),
only if visits had been registered in the
patient administration system after the
postoperative control, or data on visual
acuity (VA) before and after surgery had
not been entered in the quality control
system.
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Clinical sciencewhich time 298 had died.
16 Cataract patients have a high mean
age, and consequently a limited expected remaining lifetime.
Relatively few of those who died during the study period received
capsulotomy in comparison with the signiﬁcantly higher
proportion in the subgroup surviving 5 years after cataract
surgery. Apart from the obviously shorter follow-up time in
patients who died before 5 years had passed after the phacoe-
mulsiﬁcation, and the previously shown correlation between
increasing age and less PCO formation both in vivo and in vitro,
this ﬁnding might be explained by elderly and/or sickly patients
probably being less eager to seek medical help for deteriorating
vision due to PCO.
11 17 The data obtained here could be one
explanation for the difference between estimated and real need
for capsulotomy found by Cleary et al, as their model was built
partially on ﬁgures from post-mortem studies.
15
At 2.5 years after surgery, the three IOLs were equal regarding
the number of performed capsulotomies. After 5 years, signiﬁ-
cant differences were evident, indicating that a hydrophobic
acrylic IOL with sharp posterior edge is superior for long-term
prevention of visually disturbing PCO. Differences between the
two AMO IOLs have been shown in prospective randomised
studies.
18 19 The hydrophilic material of the BL27 appears less
favourable in terms of PCO-preventing properties. This is in
accordance with the conclusions of a study by Kugelberg et al,
where the BL27, compared with the hydrophobic acrylic IOL
Alcon AcrySof SA60AT, was associated with signiﬁcantly more
PCO formation and capsulotomies.
20 Although it is tempting to
attribute this to differing IOL material, methods using high
magniﬁcation (500e10003) scanning electron microscope
photographs have recently shown that hydrophilic acrylic IOLs
marketed as having sharp edges show signiﬁcantly rounder optic
edges than sharp-edged hydrophobic acrylic and silicone
IOLs.
21 22 Haptic design also differs between AR40 and AR40e on
the one hand and BL27 on the other, which may have conse-
quences for PCO development (ﬁgure 1).
8
Although the three IOLs differed in cross-sectional data at
5 years, the survival curves were not signiﬁcantly different with
patient death included in the analysis. This means that at any
given time during the study period, the probability that an eye
with a certain IOL will be the nextto comefor a capsulotomy has
not been shown to differ from a random outcome. This can
decrease detectability in clinical practice of whether eyes with
a certain IOL are more or less prone to require capsulotomy.
Retrospective non-randomised studies are usually attributed
a less favourable scientiﬁc status. In a recent review article,
Buehl and Findl included only prospective, randomised trials,
Figure 3 Top: age and gender distribution for patients whose eyes
(n¼900) were operated on for cataract with clear corneal incision
phacoemulsiﬁcation surgery, with implantation of foldable acrylic
intraocular lens (IOL). The overall mean age was 76.7 (females 77.4,
males 75.5), median age 78.9 (females 79.2, males 78.0). For the
separate IOLs, the mean ages were 77.9 (AR40), 77.6 (BL27) and 74.5
(AR40e). The mean age was signiﬁcantly lower for AR40e (p<0.01, t
test), but there was no statistically signiﬁcant difference in gender
distribution between the three subgroups. Bottom: age and gender
distribution for patients whose eyes received Nd:YAG-laser treatment for
visually disturbing posterior capsular opaciﬁcation (PCO) during the 5-
year follow-up period after cataract surgery (n¼216). In this group, the
overall mean age was 76.8 (females 78.0, males 74.0), median age 78.8
(females 79.0, males 77.1).
Figure 4 KaplaneMeier graph showing how the number of untreated
posterior capsules in 900 eyes operated on with phacoemulsiﬁcation
declines over time. Top curve (thick): The total incidence of capsulotomy
during a 5-year period after phacoemulsiﬁcation with implantation of an
acrylic foldable intraocular lens (IOL), in an unselected cataract
population (n¼900 intact posterior capsules at start of follow-up).
Approximately 1.5 years after phacoemulsiﬁcation, the capsulotomy rate
increases slightly. At 5 years after cataract surgery, 216 eyes had been
treated with Nd:YAG-laser. The second top curve (less thick) shows the
number of eyes with untreated posterior capsules remaining in alive
patients. With capsulotomies and patient deaths included, 441 eyes
remain eligible for future capsulotomy 5 years after cataract surgery. The
three curves at the bottom of the graph show the rates of capsulotomies
for the three IOL subgroups (n¼300 intact posterior capsules for each
subgroup at start of follow-up). With patient death included in the
analysis, differences between the three survival curves are not
statistically signiﬁcant (logrank test, p¼0.11). Of 300 eyes receiving an
AR40e, 52 were treated with Nd:YAG-laser during the follow-up period,
compared with 73 in the AR40 group and 91 in the BL27 group,
a statistically signiﬁcant difference (p<0.001, c
2 test).
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threatening ocular disease (glaucoma, corneal disease, uveitis,
traumatic or complicated cataract (eg, zonular weakness),
retinal disease or history of diabetes mellitus with diabetic
retinopathy).
13 While this approach is defensible for a review
article, one cannot avoid noticing the difference in characteristics
between these prospectively studied populations and the non-
selected population that cataract surgery centres handle in
clinical practice. Therefore, duly recognising the value of well-
designed prospective randomised studies, it seems reasonable to
study outcomes retrospectively in non-selected populations. This
will provide relevant information on the actual long-term impact
of PCO in clinical practice, also with possibilities to compare
different IOLs.
Studies such as this epidemiological, longitudinal retrospective
cohort study with capsulotomy as primary endpoint can have
difﬁculties tracking down every patient that has undergone
capsulotomy, especially with more than one care-provider in the
area. Patients with PCO on waiting lists or not seeking medical
help will not be detected.
23 Availability of, and reimbursement
for, laser treatments can also inﬂuence the outcomes.
12 When
these issues can be controlled, retrospective studies may however
provide valuable information that is impossible to access by
means of randomised prospective studies of selected patient
materials.
24 The ophthalmic healthcare infrastructure in Lin-
köping, as outlined in the Introduction, offers favourable condi-
tions for retrospective research. It is also reasonable to optimally
utilise the vast amounts of data fed into the various information
systems used in healthcare.
For dataquality, a study like this depends on the functionality of
the public healthcare system within which it has been carried out:
limited availability of Nd:YAG-laser treatment and the conse-
quently long waiting lists could lead to falsely low capsulotomy
rates,atleasttemporarily.Thelongfollow-upperiodalongwiththe
commonly short waiting lists for capsulotomy (maximum 3e4
months) should compensate for this, and the absolute numbers of
capsulotomies detected are not below what should be expected
from previous literature. Kugelberg et al admittedly describes a 2-
year capsulotomy rate in eyes with BL27 of 42% (24/57); but of
these, 16 treatments were performed at the scheduled 2-year visit
and only eight (14%) at the initiative of patients, analogously to
this study.
20 Strong features of this study are the large number of
cases, few dropouts and a long study period, all comparing well
with the studies Buehl andFindl included in their review, as well as
the absence of signiﬁcant economic obstacles and/or incentives.
13
The results of this study should be generalisable for any healthcare
system without signiﬁcant economic bias from both a patient and
a healthcare system perspective, and with good access to Nd:YAG-
laser treatment.
As a consequence of a long follow-up time, other models have
usually replaced the IOLs investigated at the time of study
publication, which is the case for all three IOLs in this study.
However, both the IOL materials and the sharp posterior optic
edge design are used in presently marketed models. Therefore,
these results can provide a basis for discussion about the long-
term economic consequences of choosing an IOL whose design
makes PCO development more or less likely.
In summary, this retrospective longitudinal follow-up study
found an overall 5-year capsulotomy incidence of 24%. Hydro-
phobic acrylic IOL material and square posterior optic edge
together were associated with signiﬁcantly lower numbers of
capsulotomies, compared with a hydrophilic IOL. The ﬁndings
provide information about the strain on the ophthalmic health-
caresystemthatdifferenttypesofIOLmaycause.Theresultsalso
suggest caution when applying conclusions from post-mortem
studies on living populations. Newer IOL models are currently
being monitored for future comparison with this study.
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